Valneva SE - VALN
Sector:
Healthcare
· Industry:
Biological Products, (No Diagnostic Substances)
Website:
No information yet
· Social:
No information yet
Company profile
Powered by TradingView
Quarter snapshot
Latest / Compare
Q3 2026
· Q2 2026
Value (USD)
Total reported value ($000)
$19.77M
QoQ value delta ($000)
+$4K
(+0.02%)
Implied price effect (QoQ)
+0.02%
Shares
Total shares
3,781,189
QoQ shares delta
-37
(-0.0%)
Total shares held by funds (by quarter)
Shares (left)
Fund holders (right)
Market chart (VALN)
Powered by TradingView
Interactive chart by
TradingView.
Top holders (Q3 2026)
Top 25 only
Full list
Partial Q3 2026 data: 2 holders have filed so far. Prior holders are carried forward until their next 13F confirms a change.
| Manager | Value ($000) | Shares | % of 13F |
|---|---|---|---|
| Frazier Life Sciences Management, L.P. | 11,985 | 2,291,666 | 0.26% |
| Vivo Capital, LLC | 3,991 | 763,199 | 0.36% |
| GENERAL AMERICAN INVESTORS CO INC | 1,853 | 354,361 | 0.11% |
| MILLENNIUM MANAGEMENT LLC | 707 | 135,223 | 0.0% |
| WELLS FARGO & COMPANY/MN | 403 | 77,214 | 0.0% |
| MORGAN STANLEY | 294 | 56,217 | 0.0% |
| IRONWOOD INVESTMENT MANAGEMENT LLC | 235 | 45,064 | 0.08% |
| CITADEL ADVISORS LLC | 106 | 20,294 | 0.0% |
| XTX Topco Ltd | 79 | 15,178 | 0.0% |
| VSM Wealth Advisory, LLC | 52 | 10,000 | 0.01% |
| GAMMA Investing LLC | 25 | 4,052 | 0.0% |
| UBS Group AG | 23 | 4,525 | 0.0% |
| RHUMBLINE ADVISERS | 9 | 1,860 | 0.0% |
| Steigerwald, Gordon & Koch Inc. | 6 | 1,250 | 0.0% |
| BNP PARIBAS FINANCIAL MARKETS | 2 | 559 | 0.0% |
| Larson Financial Group LLC | 1 | 375 | 0.0% |
| OSAIC HOLDINGS, INC. | 0 | 90 | 0.0% |
| Activest Wealth Management | 0 | 1 | 0.0% |
| Caitong International Asset Management Co., Ltd | 0 | 18 | 0.0% |
| Smartleaf Asset Management LLC | 0 | 43 | 0.0% |